Follow-up study for birdshot eye inflammation
Part of Eyes & vision, Immune system & allergy clinical trials.
This study follows people with “birdshot chorioretinopathy,” a rare eye inflammation, and collects immune (genetic) information to better understand the disease. You may benefit from closer monitoring, and the results may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have birdshot eye inflammation in both eyes (bilateral disease).
- In at least one eye, your eye exam shows three or more birdshot lesions near the optic nerve, on the lower or inner (nasal) side.
- Your eye inflammation in the front of the eye is mild (no more than 1+ cells).
- Your eye inflammation inside the eye is mild (no more than 2+ vitreous haze).
- You do not have other conditions that could explain similar eye findings (like infection, cancer, or a different inflammatory eye disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for biomarkers (clues in your body) related to abnormal blood vessels in the eye. It may help researchers understand and treat conditions like macular degeneration.
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
This study follows adults with non-infectious uveitis (intermediate, posterior, or pan-uveitis) to better understand inflammation activity and treatment needs. It also follows adults having planned eye surgery (like cataract or vitreoretinal surgery) to compare groups.
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
This trial looks at how often inflammatory flare-ups happen in patients with a type of eye inflammation called posterior uveitis. It focuses on people who have been treated with a fluocinolone acetonide implant, a tiny device placed in the eye that releases medicine over time, and aims to understand how well it controls inflammation.
Hear when a new Birdshot Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.